Next Post

CVS Health: Share Repurchases And Dividend Catalyst (NYSE:CVS)

peterschreiber.media/iStock via Getty Images CVS Health (NYSE:NYSE:CVS) posted a better balance sheet in its Q1 2022 report compared to my first analysis about them where I discussed their FY2021 report. A few weeks after that, it posted a gain of 7% better than the broader bearish market, before it got […]